Eun Mi Hur

Title: Eun Mi Hur: Innovator in Immunosuppressive Research

Introduction

Eun Mi Hur is a prominent inventor based in Kyonggi-do, South Korea. She has made significant contributions to the field of immunology through her innovative research and patenting efforts. Her work focuses on the use of natural compounds for therapeutic applications, particularly in the context of immune response modulation.

Latest Patents

Eun Mi Hur holds a patent for the "Use of rosmarinic acid and derivatives thereof as an immunosuppressant." This invention relates to the application of rosmarinic acid and its derivatives as immunosuppressive agents. The patent reveals that these compounds specifically inhibit the binding of ligand peptides to the Lck SH2 domain, disrupt Lck-mediated signal transduction in T cells, and inhibit cytokine gene expression. These properties make rosmarinic acid and its derivatives valuable for treating, preventing, and diagnosing graft rejection, graft-versus-host disease (GVHD), autoimmune diseases, and inflammatory conditions. Eun Mi Hur has 1 patent to her name.

Career Highlights

Eun Mi Hur is affiliated with the Mogam Biotechnology Research Institute, where she conducts her research. Her work has garnered attention for its potential applications in improving transplant outcomes and managing autoimmune disorders.

Collaborations

Eun Mi Hur collaborates with notable colleagues, including Young Bong Choi and Changwon Park, to advance her research initiatives.

Conclusion

Eun Mi Hur's innovative work in the field of immunology highlights the importance of natural compounds in medical research. Her contributions pave the way for new therapeutic strategies in managing immune-related conditions.